These results show that regardless of the clinical manifestation of COVID-19, the expression levels of FAS and FASL appear to be influenced by the genetic variations FAS rs1800682 (A/G) and FASL rs763110 (C/T), respectively, even in the presence of other immunological components (Table 4). Here, FAS is linked to COVID-19.